News

February 10, 2020
Trefoil Therapeutics Appoints Thomas M. Tremblay, RN BSN, Vice President, Clinical Development
Experienced clinical development executive to lead the TTHX1114  clinical study in corneal endothelial disease 

Trefoil Therapeutics today announced the appointment of Thomas M. Tremblay, RN, BSN to the newly created position of Vice President, Clinical Development. He brings to Trefoil more than 25 years of experience in pharmaceutical development across a variety of therapeutic areas.

FULL TEXT PRESS RELEASE

© 2018 by Trefoil Therapeutics, Inc.